Literature DB >> 10887488

Genetic analysis of breast cancer progression.

S H Dairkee1, H S Smith.   

Abstract

At the histological level, breast tumors display a variety of morphologic lesions which suggest the existence of an increasingly aberrant pathway of intermediate steps leading to the invasive primary tumor and its metastatic dissemination. In order to obtain direct evidence for this presumed progression, underlying genetic changes must be identified. Analyses of primary breast tumors have revealed a large number of dominant and recessive gene alterations encompassing several cellular attributes and activities. It is quite likely that some of these alterations are of a causal nature and thus enable the tumor to attain distinctive malignant phenotypes, such as, dysregulated proliferation, invasion, angiogenesis, and ability to metastasize. Considerable heterogeneity has been observed in the sequence of acquisition of these genetic changes, which is substantiated by recent comparative analyses between carefully microdissected preinvasive and invasive tumor. The data are evaluated here in the context of existing models of breast cancer progression. Implication and prospects for translational application to the clinic are also discussed.

Entities:  

Mesh:

Year:  1996        PMID: 10887488     DOI: 10.1007/BF02013638

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  107 in total

1.  Accumulation of genetic alterations and progression of primary breast cancer.

Authors:  T Sato; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

2.  Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.

Authors:  P A Futreal; P Söderkvist; J R Marks; J D Iglehart; C Cochran; J C Barrett; R W Wiseman
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

3.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

4.  Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.

Authors:  T I Andersen; A Gaustad; L Ottestad; G W Farrants; J M Nesland; K M Tveit; A L Børresen
Journal:  Genes Chromosomes Cancer       Date:  1992-03       Impact factor: 5.006

Review 5.  Tumor suppressor genes: new prospects for cancer research.

Authors:  R E Hollingsworth; W H Lee
Journal:  J Natl Cancer Inst       Date:  1991-01-16       Impact factor: 13.506

6.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

7.  Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells.

Authors:  M Balazs; K Matsumura; D Moore; D Pinkel; J W Gray; F M Waldman
Journal:  Cytometry       Date:  1995-05-01

8.  A candidate tumor suppressor gene in human breast cancers.

Authors:  D R Schott; J N Chang; G Deng; W Kurisu; W L Kuo; J Gray; H S Smith
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

9.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.

Authors:  I Ito; M Yoshimoto; T Iwase; S Watanabe; T Katagiri; Y Harada; F Kasumi; S Yasuda; T Mitomi; M Emi
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more
  1 in total

1.  Modeling the effect of tumor size in early breast cancer.

Authors:  Claire Verschraegen; Vincent Vinh-Hung; Gábor Cserni; Richard Gordon; Melanie E Royce; Georges Vlastos; Patricia Tai; Guy Storme
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.